Showing results (81-90 of 87) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Anticancer Research|February 28, 2023
Successful Identification of a Novel Therapeutic Compound for Hepatocellular Carcinoma Through Screening of ADAM9 InhibitorsKeita Ogawa, Tetsuhiro Chiba, Masato Nakamura, et al.Journal of Cancer|June 17, 2022
Effect of Atezolizumab plus Bevacizumab in Patients with Hepatocellular Carcinoma Harboring CTNNB1 Mutation in Early Clinical ExperienceKeita Ogawa, Hiroaki Kanzaki, Tetsuhiro Chiba, et al.Biochemical and Biophysical Research Communications|December 31, 2022
Miglustat, a glucosylceramide synthase inhibitor, mitigates liver fibrosis through TGF-β/Smad pathway suppression in hepatic stellate cellsTerunao Iwanaga, Tetsuhiro Chiba, Masato Nakamura, et al.BMC Gastroenterology|April 2, 2023
Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma from Japanese real-world practiceSae Yumita, Sadahisa Ogasawara, Miyuki Nakagawa, et al.Liver Cancer|February 28, 2022
Evolution of Survival Impact of Molecular Target Agents in Patients with Advanced Hepatocellular CarcinomaKazufumi Kobayashi, Sadahisa Ogasawara, Aya Takahashi, et al.Cancer|November 25, 2022
Clinical effects and emerging issues of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma from Japanese real-world practiceMiyuki Nakagawa, Masanori Inoue, Sadahisa Ogasawara, et al.Nature Communications|January 26, 2026
CXCR4 induces memory formation over exhaustion in CAR-T cells to achieve durable leukemia targetingAri Itoh-Nakadai, Minggao Liang, Michiho Shindo, et al.Pageof 9